Egalet Corp (NASDAQ:EGLT)

During the Trading Day
4.87 +0.55 / +12.73%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.87 0.00 / 0.00%
Volume: 297.00
Health Technology
Pharmaceuticals: Other

Company Description

Egalet Corp. is a specialty pharmaceutical company using its patented technology to produce novel therapeutics on its own and with partners. The company is developing a pipeline of tamper-resistant opioids that are nearing pivotal testing based on the proprietary technology. Its products include Egalet-001, Egalet-002 and AD Opioid. The company was founded in August 2013 and is headquartered in Malvern, PA.

Contact Information

Egalet Corp.
460 E. Swedesford Road
Wayne Pennsylvania 19087
P:(484) 875-3095
Investor Relations:



Individual stakeholders44.47%
Other institutional4.41%
Mutual fund holders17.18%

Top Executives

Robert Samuel RadiePresident, Chief Executive Officer & Director
Stanley J. MusialChief Financial Officer
Jeffrey M. DaynoChief Medical Officer
Karsten LindhardtVice President-Research & Development
Mark StrobeckChief Business Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.